
Last update at 2026-06-08T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Here are Greenhaven Road Capital’s Views on Cellebrite (CLBT
Thu 22 May 25, 02:37 PMCellebrite DI First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Fri 16 May 25, 10:53 AMCellebrite Announces First-Quarter 2025 Results
Wed 14 May 25, 11:00 AMCellebrite Unveils Spring 2025 Release to Accelerate Global Investigations
Tue 06 May 25, 12:30 PMCellebrite apresenta Lançamento do Primeiro Semestre de 2025 para acelerar investigações globais
Tue 06 May 25, 12:30 PMUS High Growth Tech Stocks To Watch In April 2025
Wed 02 Apr 25, 11:08 AMExploring High Growth Tech Stocks In The US Market
Wed 19 Mar 25, 05:08 PMCellebrite Files its 2024 Annual Report on Form 20-F
Tue 18 Mar 25, 01:00 PMCellebrite Announces Fourth-Quarter and Full-Year 2024 Results
Thu 13 Feb 25, 12:00 PM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 90.68M | -275.98400M | -75.56300M | 120.76M | 82.31M |
| Minority interest | - | - | - | - | - |
| Net income | 78.33M | -283.00700M | -81.10000M | 120.81M | 71.40M |
| Selling general administrative | 65.33M | 50.90M | 43.44M | 40.85M | 47.94M |
| Selling and marketing expenses | 154.81M | 132.39M | 110.81M | 97.39M | 76.39M |
| Gross profit | 400.50M | 338.61M | 271.88M | 219.91M | 203.69M |
| Reconciled depreciation | 11.87M | 10.61M | 9.92M | 9.19M | 7.09M |
| Ebit | 66.48M | 56.91M | -74.81000M | 1.04M | 13.82M |
| Ebitda | 78.35M | 67.51M | -64.79900M | 10.24M | 20.91M |
| Depreciation and amortization | 11.87M | 10.61M | 10.01M | 9.19M | 7.09M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 66.48M | 56.91M | 33.24M | 1.04M | 13.82M |
| Other operating expenses | 409.19M | 344.30M | 291.87M | 269.61M | 232.42M |
| Interest expense | 0.52M | 349.76M | 0.14M | 119.72M | 68.48M |
| Tax provision | 12.35M | 7.02M | 5.26M | -0.04500M | 10.91M |
| Interest income | 23.94M | 18.22M | 8.89M | 1.60M | 68.48M |
| Net interest income | 23.46M | -331.54100M | -82.87300M | 119.72M | 68.48M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 12.35M | 7.02M | 5.54M | -0.04500M | 10.91M |
| Total revenue | 475.68M | 401.20M | 325.11M | 270.65M | 246.25M |
| Total operating expenses | 334.02M | 281.70M | 238.64M | 218.86M | 189.87M |
| Cost of revenue | 75.17M | 62.59M | 53.23M | 50.75M | 42.56M |
| Total other income expense net | 24.20M | -332.89000M | -108.80000M | 119.72M | 68.48M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 78.33M | -283.00700M | -59.37500M | 120.81M | 71.40M |
| Net income applicable to common shares | - | - | - | 120.81M | 70.43M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 938.85M | 690.57M | 540.40M | 403.29M | 339.78M |
| Intangible assets | 81.47M | 11.31M | 10.59M | 11.25M | 11.23M |
| Earning assets | - | - | - | - | - |
| Other current assets | 26.23M | 29.07M | 25.80M | 17.09M | 12.82M |
| Total liab | 454.53M | 354.55M | 506.19M | 329.43M | 413.13M |
| Total stockholder equity | 484.32M | 336.02M | 34.21M | 73.86M | -73.34900M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 348.83M | 61.91M | 43.98M | 45.45M | 54.04M |
| Common stock | - | - | - | - | - |
| Capital stock | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Retained earnings | -86.53800M | -164.86400M | 118.14M | 199.24M | 78.44M |
| Other liab | - | - | - | 111.30M | 226.56M |
| Good will | 119.56M | 28.71M | 26.83M | 26.83M | 26.83M |
| Other assets | - | - | - | 14.24M | 11.76M |
| Cash | 124.46M | 191.66M | 189.52M | 87.64M | 145.97M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 369.66M | 295.50M | 253.82M | 207.78M | 186.57M |
| Current deferred revenue | - | 217.64M | 196.59M | 152.71M | 122.98M |
| Net debt | -101.78700M | -180.69000M | -175.38800M | -72.28900M | -145.97300M |
| Short term debt | 4.00M | 4.12M | 4.97M | 5.00M | - |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 22.67M | 10.97M | 14.13M | 15.36M | - |
| Other stockholder equity | 568.64M | 498.80M | -84.98100M | -125.70900M | -153.15700M |
| Property plant equipment | - | - | - | 32.91M | 16.76M |
| Total current assets | 575.85M | 567.59M | 416.53M | 295.93M | 273.21M |
| Long term investments | 97.96M | 36.60M | 28.86M | 22.12M | - |
| Net tangible assets | - | - | - | 35.78M | -111.40400M |
| Short term investments | 312.59M | 255.56M | 113.41M | 95.98M | 35.59M |
| Net receivables | 104.97M | 82.36M | 77.27M | 78.76M | 67.50M |
| Long term debt | - | - | - | - | - |
| Inventory | 7.60M | 8.94M | 10.54M | 10.18M | 6.51M |
| Accounts payable | 16.83M | 11.08M | 8.28M | 4.61M | 9.55M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 2.22M | 2.09M | 1.05M | 0.33M | 1.37M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 25.50M | 7.68M | 12.89M | 1.73M | 1.96M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 363.00M | 122.97M | 123.86M | 107.36M | 66.57M |
| Capital lease obligations | 22.67M | 10.97M | 14.13M | 15.36M | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -107.56900M | -149.47300M | -63.14400M | -91.23100M | 73.34M |
| Change to liabilities | - | - | - | 33.49M | 26.04M |
| Total cashflows from investing activities | -268.25000M | -149.47300M | -22.54000M | -91.23100M | 45.23M |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | 29.64M | 20.65M | 21.77M | 13.97M | -68.39700M |
| Change to operating activities | - | - | - | -19.74900M | -1.60700M |
| Net income | 78.33M | -283.00700M | -81.10000M | 120.81M | 71.40M |
| Change in cash | -67.20200M | 2.14M | 101.87M | -58.32800M | 12.13M |
| Begin period cash flow | 191.66M | 189.52M | 87.64M | 145.97M | 133.85M |
| End period cash flow | 124.46M | 191.66M | 189.52M | 87.64M | 145.97M |
| Total cash from operating activities | 168.96M | 132.17M | 102.06M | 20.58M | 36.05M |
| Issuance of capital stock | - | - | - | - | 0.00000M |
| Depreciation | 11.87M | 10.61M | 10.01M | 9.19M | 7.09M |
| Other cashflows from investing activities | 0.86M | -2.04300M | -2.68700M | - | - |
| Dividends paid | - | - | 0.00000M | 0.00000M | 100.00M |
| Change to inventory | 1.63M | 0.98M | 0.24M | -3.68000M | -1.79800M |
| Change to account receivables | -15.78100M | -5.82900M | 2.27M | -12.88500M | -1.95800M |
| Sale purchase of stock | - | -0.01100M | - | 0.00000M | 0.00000M |
| Other cashflows from financing activities | 25.05M | 20.65M | 21.77M | 13.97M | 31.60M |
| Change to netincome | - | - | - | -106.60300M | -63.03100M |
| Capital expenditures | 13.22M | 10.61M | 7.92M | 9.09M | 8.11M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 42.02M | 42.05M | 38.52M | -2.81900M | 20.59M |
| Stock based compensation | 44.89M | 30.57M | 19.00M | 13.71M | 6.48M |
| Other non cash items | 36.67M | 335.96M | 110.50M | -117.91900M | -67.86300M |
| Free cash flow | 155.73M | 121.56M | 94.14M | 11.49M | 27.94M |
Sector: Technology Industry: Software - Infrastructure
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLBT Cellebrite DI |
-0.38 2.75% | 13.43 | 43.16 | 35.71 | 7.02 | 6.89 | 6.15 | 28.36 |
| MSFT Microsoft Corporation |
-4.93 1.18% | 411.74 | 37.32 | 29.94 | 13.03 | 12.45 | 13.06 | 24.59 |
| ORCL Oracle Corporation |
-1.86 0.87% | 211.82 | 29.34 | 18.66 | 5.55 | 74.06 | 7.10 | 18.13 |
| CRWD Crowdstrike Holdings Inc |
-12.23 1.82% | 658.79 | - | 89.29 | 23.70 | 24.81 | 21.91 | 577.82 |
| PANW Palo Alto Networks Inc |
-5.72 2.10% | 266.33 | 44.57 | 45.05 | 11.98 | 20.70 | 11.82 | 77.11 |
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602
| Name | Title | Year Born |
|---|---|---|
| Mr. Yossi Carmil | Founder, CEO & Director | 1967 |
| Ms. Dana Gerner | Chief Financial Officer | 1967 |
| Mr. Arnon Zilberman | Exec. VP of Information Systems & Operations | NA |
| Mr. Ronnen Armon | Chief Products & Technologies Officer | 1963 |
| Anat Earon-Heilborn | VP of Investor Relations | NA |
| Ms. Ayala Berler Shapira | Gen. Counsel | NA |
| Adam Jaffe | VP of Global Communications | NA |
| Ms. Osnat Tirosh | Chief People & Corp. Devel. Officer | 1969 |
| Ms. Lisa Cole | Chief Marketing Officer | NA |
| Mr. Leeor Ben-Peretz | Chief Strategy Officer | 1976 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.